University of Leicester
Browse
2014KholghiAOAPhD.pdf (4.48 MB)

Pharmacological investigation of clinically achievable concentrations of resveratrol in colorectal cancer

Download (4.48 MB)
thesis
posted on 2014-11-05, 11:43 authored by Abeer Othman A. Kholghi
Resveratrol, a polyphenol present in red wine and peanuts exerts an array of beneficial effects, including anticancer activity and calorie restriction (CR) mimicry. Work from our laboratory has shown for the first time that low doses of resveratrol, comparable to amounts contained in a glass of red wine significantly reduced adenoma development in ApcMin/+ mice when given with a high fat diet. The protective effect was more pronounced than that caused by higher amounts, equivalent to doses used in clinical trials. The CR activity of resveratrol is mediated via the energy regulator AMP-activated kinase (AMPK). This study aims to investigate whether AMPK signalling contributes to the chemopreventive effect of resveratrol. The extent of AMPK activation in vivo correlated with the degree of adenoma inhibition; AMPK expression and phosphorylation was evident in mucosa of resveratrol treated mice, but not in control animals, with highest levels in those that ingested the low dose. This chronic resveratrol treatment was also associated with increased expression of p21, a biomarker of senescence, particularly at the low dose. Moreover, we identify a bell-shaped dose-response to resveratrol: In Apc10.1 cells resveratrol caused significant increases in AMPK phosphorylation at 0.01, 0.1 and 1μM, but not at 10μM, consistent with a bell-shaped dose-response. Activity was accompanied by significantly reduced phosphorylation of mTOR, which is regulated by AMPK signalling, plus its downstream targets p70S6K and 4E-BP1. Furthermore, these concentrations also increased autophagy and senescence, as measured by LC3-II and p21 expression, respectively. Modulation of cellular energy balance by increasing the AMP/ATP and/or ADP/ATP ratios and ability of resveratrol to produce ROS are most likely to be two of the mechanisms responsible for resveratrol stimulating AMPK activation in Apc10.1cells. The novel finding that low amounts of resveratrol are more efficient than higher does will influence future attempts towards clinical implementation of resveratrol for cancer chemoprevention.

History

Supervisor(s)

Brown, Karen

Date of award

2014-04-01

Author affiliation

Department of Cancer Studies & Molecular Medicine

Awarding institution

University of Leicester

Qualification level

  • Doctoral

Qualification name

  • PhD

Language

en

Usage metrics

    University of Leicester Theses

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC